£2,000 to invest? I’d buy these 2 dividend shares for my ISA

If you’re looking to invest in an ISA, these companies won’t let you down says Rupert Hargreaves.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

If you have just £2,000 to invest in a Stocks and Shares ISA, then I highly recommend deploying some of this cash into flexible office provider IWG (LSE: IWG). 

IWG, or Regus as it was formerly known, calls itself a “global operator of leading co-work and workspace brands.” Business is booming in this section of the office market as self-employment and flexible working becomes the norm for millions of workers around the world who want more from their jobs. Larger companies are also rushing to lease space because providers like IWG offer more flexible contracts, unlike traditional leases, which can tie tenants in for decades. 

IWG has invested hundreds of millions of pounds in its office estate in the past few years to attract more customers and it seems to be working.

Earnings growth

For the six months ended 30 June, revenue increased 17.3% in actual currency, and gross profit increased 7% year-on-year. Profit after tax, including discontinued operations, jumped 579% to £294m. Earnings per share from continuing operations came in at 4.2p for the first half of IWG’s 2019 financial year. 

Its income in the period received a boost from its £320m partnership transaction in Japan, which was just one of the “multiple” franchise agreements the group has signed over the past few months. Including cash generated from operations, this transaction boosted IWG’s cash inflow to £385m in the first half. 

Management is investing around two-thirds of this income back into its office portfolio, and the rest is being paid out to investors. The interim dividend is rising 10.3%, and the firm is spending £100m repurchasing shares. 

These results seem to put the company well on the way to meeting City growth forecasts for the year. Analysts have pencilled in earnings of 12.3p per share for 2019, and 14p for 2020, putting the stock on a forward P/E of 29.3. This is above what I would usually be willing to pay for a low-growth business like IWG.

However, the company’s international presence, cash generation and record of returning excess funds to investors lead me to the conclusion that this might be an attractive investment for your stocks and shares ISA today. The dividend has doubled over the past five years, and the current yield stands at 1.9%. 

Defensive income

Another income investment that I think might be worth your research time is healthcare facility provider Assura (LSE: AGR). I think this healthcare real estate investment trust is one of the most defensive investments you can buy today.

The business model is simple. The company buys specialist healthcare facilities and then leases them to healthcare providers, predominantly the NHS. This model generates a steady stream of income, which it then returns to shareholders. Over the past five years, Assura’s dividend yield has grown by around 50% as its property portfolio has nearly tripled in value.

Today, shares in the healthcare REIT support a dividend yield of 4.3%, and analysts believe the payout will increase by 4% by 2021, giving a yield of 4.5%. Book value per share (the total value of the company’s property assets minus borrowing) was 53.4p at the end of its last reported financial year. On this basis, the stock is currently trading above book value, but once again, I think it’s worth paying a premium to get your hands on shares in this one-of-a-kind business. 

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Rupert Hargreaves owns no share mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »